Elizabeth Garrett-Mayer to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Drug Resistance, Neoplasm.
Connection Strength
0.121
-
Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer. Clin Cancer Res. 2010 Jan 01; 16(1):203-11.
Score: 0.070
-
Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia. 2012 Aug; 14(8):690-701.
Score: 0.021
-
Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proc Natl Acad Sci U S A. 2008 Jan 08; 105(1):288-93.
Score: 0.015
-
Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer. J Clin Oncol. 2007 Sep 01; 25(25):3965-70.
Score: 0.015